Galectin Therapeutics
GALT
#9249
Rank
S$88.42 M
Marketcap
$1.41
Share price
-48.00%
Change (1 day)
-40.33%
Change (1 year)

Galectin Therapeutics (GALT) Fails to deliver data

Key failure to deliver metrics for Galectin Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Galectin Therapeutics (GALT) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Galectin Therapeutics (GALT) - since 2013

Volume in USD (price x number of shares), data since 2013

Galectin Therapeutics (GALT) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024S$2.51 M4066.87%
2023S$0.06 M-92.09%
2022S$0.76 M-94.05%
2021S$12.84 M209.49%
2020S$4.15 M-67.22%
2019S$12.65 M-68.49%
2018S$40.17 M328.61%
2017S$9.37 M-2.44%
2016S$9.6 M106.82%
2015S$4.64 M-87.58%
2014S$37.39 M175.03%
2013S$13.59 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
N/AS$7.06 M๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.43 MS$13.55 M๐Ÿ‡บ๐Ÿ‡ธ USA